CN114223904A - 一种美白抗糖保健品的配方 - Google Patents
一种美白抗糖保健品的配方 Download PDFInfo
- Publication number
- CN114223904A CN114223904A CN202111648257.4A CN202111648257A CN114223904A CN 114223904 A CN114223904 A CN 114223904A CN 202111648257 A CN202111648257 A CN 202111648257A CN 114223904 A CN114223904 A CN 114223904A
- Authority
- CN
- China
- Prior art keywords
- parts
- component
- extract
- whitening
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000002087 whitening effect Effects 0.000 title claims abstract description 26
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 claims abstract description 32
- 239000000047 product Substances 0.000 claims abstract description 30
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 24
- 239000000284 extract Substances 0.000 claims abstract description 22
- 229940054810 white kidney bean extract Drugs 0.000 claims abstract description 20
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 claims abstract description 17
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims abstract description 17
- 108010024636 Glutathione Proteins 0.000 claims abstract description 16
- 229960003180 glutathione Drugs 0.000 claims abstract description 16
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 12
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 12
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 12
- 239000011718 vitamin C Substances 0.000 claims abstract description 12
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 6
- 108010020346 Polyglutamic Acid Proteins 0.000 claims abstract description 6
- 229920002643 polyglutamic acid Polymers 0.000 claims abstract description 6
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 claims abstract description 3
- 241000195493 Cryptophyta Species 0.000 claims abstract description 3
- 241000196324 Embryophyta Species 0.000 claims abstract description 3
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 3
- 244000068988 Glycine max Species 0.000 claims abstract description 3
- 229930194248 Licoflavone Natural products 0.000 claims abstract description 3
- MEHHCBRCXIDGKZ-UHFFFAOYSA-N Licoflavone C Natural products CC(C)=CCC1=C(O)C=C(O)C(C(C=2)=O)=C1OC=2C1=CC=C(O)C=C1 MEHHCBRCXIDGKZ-UHFFFAOYSA-N 0.000 claims abstract description 3
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 3
- 235000013793 astaxanthin Nutrition 0.000 claims abstract description 3
- 239000001168 astaxanthin Substances 0.000 claims abstract description 3
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 claims abstract description 3
- 229940022405 astaxanthin Drugs 0.000 claims abstract description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 3
- 235000002532 grape seed extract Nutrition 0.000 claims abstract description 3
- 229940087603 grape seed extract Drugs 0.000 claims abstract description 3
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 claims abstract description 3
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 claims abstract description 3
- 235000008696 isoflavones Nutrition 0.000 claims abstract description 3
- 150000008442 polyphenolic compounds Chemical class 0.000 claims abstract description 3
- 235000013824 polyphenols Nutrition 0.000 claims abstract description 3
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 3
- 229940046009 vitamin E Drugs 0.000 claims abstract description 3
- 239000011709 vitamin E Substances 0.000 claims abstract description 3
- 239000001717 vitis vinifera seed extract Substances 0.000 claims abstract description 3
- 239000000203 mixture Substances 0.000 claims description 17
- 235000013557 nattō Nutrition 0.000 claims description 16
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 claims description 14
- 239000000843 powder Substances 0.000 claims description 13
- LXBIFEVIBLOUGU-UHFFFAOYSA-N Deoxymannojirimycin Natural products OCC1NCC(O)C(O)C1O LXBIFEVIBLOUGU-UHFFFAOYSA-N 0.000 claims description 6
- 241000186660 Lactobacillus Species 0.000 claims description 6
- LXBIFEVIBLOUGU-JGWLITMVSA-N duvoglustat Chemical compound OC[C@H]1NC[C@H](O)[C@@H](O)[C@@H]1O LXBIFEVIBLOUGU-JGWLITMVSA-N 0.000 claims description 6
- 229940039696 lactobacillus Drugs 0.000 claims description 6
- 238000009472 formulation Methods 0.000 claims description 5
- 229940086319 nattokinase Drugs 0.000 claims description 4
- 108010073682 nattokinase Proteins 0.000 claims description 4
- 241000194108 Bacillus licheniformis Species 0.000 claims description 2
- 244000063299 Bacillus subtilis Species 0.000 claims description 2
- 235000014469 Bacillus subtilis Nutrition 0.000 claims description 2
- 229920001202 Inulin Polymers 0.000 claims description 2
- 239000002775 capsule Substances 0.000 claims description 2
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims description 2
- 229940107187 fructooligosaccharide Drugs 0.000 claims description 2
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 2
- 229940029339 inulin Drugs 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims 2
- 239000003381 stabilizer Substances 0.000 claims 2
- 229960002685 biotin Drugs 0.000 claims 1
- 235000020958 biotin Nutrition 0.000 claims 1
- 239000011616 biotin Substances 0.000 claims 1
- 239000003826 tablet Substances 0.000 claims 1
- 229930003231 vitamin Natural products 0.000 claims 1
- 235000013343 vitamin Nutrition 0.000 claims 1
- 239000011782 vitamin Substances 0.000 claims 1
- 229940088594 vitamin Drugs 0.000 claims 1
- 150000003722 vitamin derivatives Chemical class 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 8
- 238000012423 maintenance Methods 0.000 abstract description 3
- 235000013406 prebiotics Nutrition 0.000 abstract description 3
- 239000006041 probiotic Substances 0.000 abstract description 3
- 235000018291 probiotics Nutrition 0.000 abstract description 3
- BGMYHTUCJVZIRP-UHFFFAOYSA-N Nojirimycin Natural products OCC1NC(O)C(O)C(O)C1O BGMYHTUCJVZIRP-UHFFFAOYSA-N 0.000 abstract 1
- 230000007413 intestinal health Effects 0.000 abstract 1
- BGMYHTUCJVZIRP-GASJEMHNSA-N nojirimycin Chemical compound OC[C@H]1NC(O)[C@H](O)[C@@H](O)[C@@H]1O BGMYHTUCJVZIRP-GASJEMHNSA-N 0.000 abstract 1
- 238000002156 mixing Methods 0.000 description 19
- 238000002360 preparation method Methods 0.000 description 9
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 8
- 229940016286 microcrystalline cellulose Drugs 0.000 description 8
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 8
- 239000008108 microcrystalline cellulose Substances 0.000 description 8
- 239000002994 raw material Substances 0.000 description 8
- 238000003756 stirring Methods 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- 230000001804 emulsifying effect Effects 0.000 description 6
- 239000000905 isomalt Substances 0.000 description 6
- 235000010439 isomalt Nutrition 0.000 description 6
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 description 6
- 235000015112 vegetable and seed oil Nutrition 0.000 description 6
- 239000008158 vegetable oil Substances 0.000 description 6
- 229920002472 Starch Polymers 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000008107 starch Substances 0.000 description 5
- 235000019698 starch Nutrition 0.000 description 5
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 4
- 229920001661 Chitosan Polymers 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 4
- 229940041514 candida albicans extract Drugs 0.000 description 4
- 230000015556 catabolic process Effects 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 238000006731 degradation reaction Methods 0.000 description 4
- 210000001035 gastrointestinal tract Anatomy 0.000 description 4
- 235000010413 sodium alginate Nutrition 0.000 description 4
- 239000000661 sodium alginate Substances 0.000 description 4
- 229940005550 sodium alginate Drugs 0.000 description 4
- 239000012138 yeast extract Substances 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 239000004382 Amylase Substances 0.000 description 2
- 108010065511 Amylases Proteins 0.000 description 2
- 102000013142 Amylases Human genes 0.000 description 2
- 240000000249 Morus alba Species 0.000 description 2
- 235000008708 Morus alba Nutrition 0.000 description 2
- 102000003425 Tyrosinase Human genes 0.000 description 2
- 108060008724 Tyrosinase Proteins 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 235000019418 amylase Nutrition 0.000 description 2
- 239000003392 amylase inhibitor Substances 0.000 description 2
- XHCADAYNFIFUHF-TVKJYDDYSA-N esculin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC2=C1OC(=O)C=C2 XHCADAYNFIFUHF-TVKJYDDYSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 235000004252 protein component Nutrition 0.000 description 2
- 230000002040 relaxant effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 1
- 229940122816 Amylase inhibitor Drugs 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 108010001394 Disaccharidases Proteins 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 101710184309 Probable sucrose-6-phosphate hydrolase Proteins 0.000 description 1
- 102400000472 Sucrase Human genes 0.000 description 1
- 101710112652 Sucrose-6-phosphate hydrolase Proteins 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000013061 administrable dose form Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 235000021152 breakfast Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 235000011073 invertase Nutrition 0.000 description 1
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000008099 melanin synthesis Effects 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 229940038580 oat bran Drugs 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 235000021119 whey protein Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/14—Yeasts or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
- A23P10/28—Tabletting; Making food bars by compression of a dry powdered mixture
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/40—Shaping or working of foodstuffs characterised by the products free-flowing powder or instant powder, i.e. powder which is reconstituted rapidly when liquid is added
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Botany (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
本发明公开了一种美白抗糖保健品的配方。以重量份数计,本发明配方包括:第一组分10‑65份,第二组分20‑50份;其中:第一组分选自谷胱甘肽、酵母类产品、虾青素、藻类产品、维生素C、葡萄籽提取物、SOD、维生素E、大豆异黄酮、甘草黄酮、甘草提取物、植物多酚中的一种或几种,第二组分选自白芸豆提取物、L‑阿拉伯糖、桑叶提取物或野尻霉素中的一种或几种。本发明将具有抗糖功效与美白功效成分进行了科学的组合,可同时实现美白与抗糖减肥的功能。此外,本发明在配方中还添加含有聚谷氨酸成分的第三组分加强维护美白效果,利用益生元和益生菌等倡导功能组分维护肠道健康。本发明配方具有更明显和持久的美白功能。
Description
技术领域
本发明属于健康食品技术领域,具体的说,涉及一种美白抗糖保健品的配方。
背景技术
美白是美容领域的重要研究目标,通过口服健康产品实现美白主要有两个途径:1.抑制酪氨酸酶活性,减少黑色素的产生;2.降低血糖,防止皮肤糖化暗沉。
中国专利CN 112868805 A提及了一种具有降血糖功能的食品,原料及各原料重量份数配比为:燕麦麸皮粉45-70份、脱脂奶粉20-30份、抗性糊精5-8份、β-葡聚糖15-24份、低聚异麦芽糖4-8份、浓缩乳清蛋白粉15-20份、黄精5-9份、白芸豆提取物18-26份、赤藓糖醇5-10份、L-阿拉伯糖3-7份、增稠剂2-5份、食用香精0 .5-2份。中国专利CN 111567664 A、CN112568431 A等也提到了利用白芸豆提取物和L-阿拉伯糖来降低餐后血糖。白芸豆提取物是淀粉酶抑制剂,可以抑制淀粉的降解;L-阿拉伯糖是二糖酶抑制剂,可以抑制二糖转化为单糖,这两种成分具有充足的降低血糖的科学依据。
发明内容
针对现有技术的不足,本发明公布了一种美白抗糖保健品的配方。该配方产品将抗糖与美白成分进行了科学的组合,可同时实现美白与抗糖减肥的功能。本配方还同时建议添加纳豆类等产品,起到增效作用。此外,由于控制血糖的成分其主要原理是抑制淀粉和糖的降解,这样会有相对较多的残余物需要及时排出体外,否则将会成为肠道有害菌生长的原料,造成便秘、口臭等不良影响,因此,本发明在配方中建议添加益生元、益生菌,以便于润肠通便,维护肠道健康。
本发明的技术方案具体介绍如下。
一种美白抗糖保健品的配方,以重量份数计,配方中包括以下组分:第一组分 10-65份,第二组分 20-50份;其中:第一组分选自谷胱甘肽、酵母类产品、虾青素、藻类产品、维生素C、葡萄籽提取物、SOD、维生素E、大豆异黄酮、甘草黄酮、甘草提取物、植物多酚中的一种或几种,第二组分选自白芸豆提取物、L-阿拉伯糖、桑叶提取物或脱氧野尻霉素中的一种或几种。
本发明中,第一组分包括谷胱甘肽、酵母类产品或维生素C中的两种;第二组分包括白芸豆提取物和L-阿拉伯糖。
本发明中,以重量份数计,配方中 还包括1-10份的第三组分;其中:第三组分选
自纳豆提取物、纳豆、聚谷氨酸或纳豆激酶中的一种或几种。
本发明中,以重量份数计,配方中还包括5-30重量份的第四组分;其中: 第四组
分选自低聚果糖、低聚木糖、菊粉、乳酸菌、枯草芽孢杆菌、地衣芽孢杆菌或酵母菌中的一种 或几种。
本发明中,还包括一定重量份的甜味剂,用于调节入口的口感。
本发明中,还包括其他一些添加剂或辅料,用于加工成可服用剂型。
本发明进一步提供一种根据上述的配方制成的胶囊、片剂、粉末或口服液。
和现有技术相比,本发明的有益效果在于:
本发明中,第一组分具有抗氧化、美白功能,美白主要的实现途径是抗氧化,抑制酪氨酸酶的活性,虽然这些成分具有一定的美白功能,但是如果不注意饮食,过量进食糖、淀粉等,将会造成皮肤胶原蛋白的糖化,使皮肤暗黄。因此利用具有抗糖功能的第二组分增强或长时间维持美白效果,这些成分是淀粉酶或蔗糖酶的抑制物,可阻止人体对淀粉和糖的降解与吸收;进一步的,利用都含有聚谷氨酸成分的第三组分加强维护美白效果,因为聚谷氨酸是一种高分子生物材料,侧链基团带有电荷,可吸附或包裹其他分子,避免被胃部的消化酶或胃酸破坏,对功能性生物分子起到保护作用,例如白芸豆提取物中起到淀粉酶抑制作用的是一种30KD左右的蛋白分子,添加含有聚谷氨酸的成分可保护该分子不被降解,提高抑制淀粉酶活性的效果;更进一步的,由于第二组分的使用使得淀粉和糖类在肠道内的降解和吸收被抑制,将会增加肠道的排泄负担,容易造成便秘等问题,因此通过第四组分即添加益生元和益生菌等方式有效防止便秘的发生,预防因为便秘原因造成的皮肤黯淡问题。综上,本发明的组合物配方具有更明显和持久的美白功能,同时根据组分的不同,还可同时具备润肠通便、护肝、疏通血管等功能。
具体实施方式
下面给出配方实例,以对本发明作出进一步的描述。
实施例中,为了防止胃液对蛋白成份的降解,将白芸豆提取物、纳豆提取物(聚谷氨酸)等蛋白成分溶解于水中,加入其它带正电荷的多糖类成分,包括但不限于(海藻酸钠、壳聚糖、可溶性葡聚糖)搅拌混合,分散均匀后缓慢倒入大豆油中乳化均质,静置后离心取沉淀,清洗后低温干燥,磨碎成粉后,再和其他成分进行混合,制备美白抗糖保健品。
实施例1
制备1公斤压片糖果产品:按照重量份数计,其通过以下主要原料制备获得:谷胱甘肽25份,维C2.5份,白芸豆提取物20份,L-阿拉伯糖12.5份,纳豆提取物 5份, 低聚木糖18份,异麦芽糖酮醇12份,微晶纤维素5份。
制备方法如下:
将白芸豆提取物和纳豆提取物 混合后溶解于5倍水中,加入总体积3%的海藻酸钠,搅拌混合,将混合物倒入10倍体积植物油中,进行乳化均质,静置30分钟后,离心,离心产物经低温干燥,粉碎后与谷胱甘肽,维C2., L-阿拉伯糖, 低聚木糖,异麦芽糖酮醇,微晶纤维素混合均匀,经过压片,得到产品。
实施例2
制备1公斤粉末状该产品:按照重量份数计,其通过以下主要原料制备获得:
酵母提取物52份,维C2.5份,白芸豆提取物20份,L-阿拉伯糖12.5份,纳豆提取物5份,低聚木糖8份。
制备方法如下:
将白芸豆提取物、纳豆提取物混合后溶解于5倍水中,加入总体积3%的海藻酸钠,搅拌混合,将混合物倒入10倍体积植物油中,进行乳化均质,静置30分钟后,离心,离心产物经低温干燥,粉碎后与酵母提取物,维C2,L-阿拉伯糖,低聚木糖,混合均匀,得到产品。
实施例3
制备1公斤压片糖果产品:按照重量份数计,其通过以下主要原料制备获得:
谷胱甘肽25份,维C2.5份,白芸豆提取物20份, L-阿拉伯糖12.5份,纳豆提取物5份,低聚木糖18份,异麦芽糖酮醇12份,微晶纤维素5份。
制备方法如下:
将白芸豆提取物、纳豆提取物溶解于5倍水中,加入总体积3%的壳聚糖,搅拌混合,将混合物倒入10倍体积植物油中,进行乳化均质,静置30分钟后,离心,离心产物经低温干燥,粉碎后与谷胱甘肽,维C, L-阿拉伯糖,低聚木糖,异麦芽糖酮醇和微晶纤维素混合均匀,经过压片,得到该产品。
实施例4
制备1公斤压片糖果产品:按照重量份数计,其通过以下主要原料制备获得:
酵母提取物50份,乳酸菌菌粉2.5份,脱氧野尻霉素34.5份,纳豆提取物5份,低聚木糖8份,微晶纤维素2份。
制备方法如下:
将乳酸菌菌粉和纳豆提取物混合后溶解于5倍水中,加入总体积3%的壳聚糖,搅拌混合,将混合物倒入10倍体积植物油中,进行乳化均质,静置30分钟后,离心,离心产物经低温干燥,粉碎后与酵母提取物,脱氧野尻霉素,低聚木糖和微晶纤维素混合均匀,经过压片得到该产品。
实施例5
制备1公斤粉末状该产品:按照重量份数计,其通过以下主要原料制备获得:
谷胱甘肽25份,维C2.5份,脱氧野尻霉素32.5份,纳豆提取物5份,低聚木糖18份,乳酸菌菌粉10份。
制备方法如下:
将乳酸菌菌粉和纳豆提取物混合后溶解于5倍水中,加入总体积3%的壳聚糖,搅拌混合,将混合物倒入10倍体积植物油中,进行乳化均质,静置30分钟后,离心,离心产物经低温干燥,粉碎后与谷胱甘肽、维C、脱氧野尻霉素、低聚木糖等组分混合均匀,得到产品。
实施例6
制备1公斤压片糖果该产品:按照重量份数计,其通过以下主要原料制备获得:
谷胱甘肽28份,维C2.5份,白芸豆提取物20份,桑叶提取物13.5份,纳豆激酶1份,低聚木糖18份,异麦芽糖酮醇12份,微晶纤维素5份。
制备方法如下:
将白芸豆提取物和纳豆提取物混合后溶解于5倍水中,加入总体积3%的海藻酸钠,搅拌混合,将混合物倒入10倍体积植物油中,进行乳化均质,静置30分钟后,离心,离心产物经低温干燥,粉碎后与谷胱甘肽,维C, L-阿拉伯糖,低聚木糖,异麦芽糖酮醇,微晶纤维素,纳豆激酶和桑叶提取物混合均匀后,经过压片得到该产品。
应用性能测试:
使用皮肤测试仪检测皮肤色度,通过检测皮肤色度验证抗糖美白效果。
对照组为不服用任何成分,美白组只服用谷胱甘肽,美白抗糖组服用等量的谷胱甘肽+白芸豆提取物+L-阿拉伯糖(重量份数分别为20份、20份、20份,将三种组分混合均匀后使用,早、中、晚餐前分别服用3克)。白皙值1,2分别是在服用功能成分2个月与3个月的测试值。取同一部位检测5次,取平均值。
表1.添加和不添加抗糖成分对谷胱甘肽美白效果的影响
由表1可见,服用抗糖成分:白芸豆提取物+L-阿拉伯糖可增强或维护美白成分的效果。
Claims (5)
1.一种美白抗糖保健品的配方,其特征在于,以重量份数计,配方中包括以下组分:第
一组分 10-65份,第二组分 20-50份;其中:第一组分选自谷胱甘肽、酵母类产品、虾青素、藻类产品、维生素C、葡萄籽提取物、SOD、维生素E、大豆异黄酮、甘草黄酮、甘草提取物、植物多酚中的一种或几种,第二组分选自白芸豆提取物、L-阿拉伯糖、桑叶提取物或脱氧野尻霉素中的一种或几种。
2.根据权利要求1所述的配方,其特征在于,第一组分包括谷胱甘肽、酵母类产品或维
生素C中的两种;第二组分包括白芸豆提取物和L-阿拉伯糖。
3.根据权利要求1所述的配方,其特征在于,以重量份数计,配方中 还包括1-10份的
第三组分;其中:第三组分选自纳豆提取物、纳豆、聚谷氨酸或纳豆激酶中的一种或几种。
4.根据权利要求1所述的配方,其特征在于,以重量份数计,配方中还包括5-30重量份
的第四组分;其中:第四组分选自低聚果糖、低聚木糖、菊粉、乳酸菌、枯草芽孢杆菌、地衣芽孢杆菌或酵母菌中的一种 或几种。
5.一种基于根据权利要求1-4之一所述的配方制成的胶囊、片剂、粉末或口服液。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111648257.4A CN114223904B (zh) | 2021-12-31 | 2021-12-31 | 一种美白抗糖保健品的配方 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111648257.4A CN114223904B (zh) | 2021-12-31 | 2021-12-31 | 一种美白抗糖保健品的配方 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114223904A true CN114223904A (zh) | 2022-03-25 |
CN114223904B CN114223904B (zh) | 2024-02-23 |
Family
ID=80744565
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111648257.4A Active CN114223904B (zh) | 2021-12-31 | 2021-12-31 | 一种美白抗糖保健品的配方 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114223904B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117617504A (zh) * | 2024-01-16 | 2024-03-01 | 馨辰生物(广东)有限公司 | 抗糖抗氧化类组合物及其制备方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103690609A (zh) * | 2013-12-31 | 2014-04-02 | 南方医科大学 | 一种美白祛斑的中药组合物及其制备方法 |
CN105434248A (zh) * | 2015-12-10 | 2016-03-30 | 青岛海特新蓝生物科技有限公司 | 一种含有熊果苷、桑叶提取物和甘草提取物的美白化妆品 |
CN107281032A (zh) * | 2017-07-01 | 2017-10-24 | 马南行 | 一种美白祛斑的组合物及其制备方法 |
CN108618134A (zh) * | 2018-05-03 | 2018-10-09 | 江苏二十维生物科技有限公司 | 一种健康饮食干预品及其制备方法和应用 |
CN109965219A (zh) * | 2019-03-22 | 2019-07-05 | 广州金酮特殊医用食品有限公司 | 一种纳豆粉的制备方法及含有纳豆粉的美白祛斑营养组合物 |
CN111034999A (zh) * | 2019-12-31 | 2020-04-21 | 北京康比特体育科技股份有限公司 | 一种具有抗糖减重功能的组合物 |
-
2021
- 2021-12-31 CN CN202111648257.4A patent/CN114223904B/zh active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103690609A (zh) * | 2013-12-31 | 2014-04-02 | 南方医科大学 | 一种美白祛斑的中药组合物及其制备方法 |
CN105434248A (zh) * | 2015-12-10 | 2016-03-30 | 青岛海特新蓝生物科技有限公司 | 一种含有熊果苷、桑叶提取物和甘草提取物的美白化妆品 |
CN107281032A (zh) * | 2017-07-01 | 2017-10-24 | 马南行 | 一种美白祛斑的组合物及其制备方法 |
CN108618134A (zh) * | 2018-05-03 | 2018-10-09 | 江苏二十维生物科技有限公司 | 一种健康饮食干预品及其制备方法和应用 |
CN109965219A (zh) * | 2019-03-22 | 2019-07-05 | 广州金酮特殊医用食品有限公司 | 一种纳豆粉的制备方法及含有纳豆粉的美白祛斑营养组合物 |
CN111034999A (zh) * | 2019-12-31 | 2020-04-21 | 北京康比特体育科技股份有限公司 | 一种具有抗糖减重功能的组合物 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117617504A (zh) * | 2024-01-16 | 2024-03-01 | 馨辰生物(广东)有限公司 | 抗糖抗氧化类组合物及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN114223904B (zh) | 2024-02-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2005283330B2 (en) | Carbohydrase inhibitors derived from chestnut and use thereof | |
EP2185011B1 (en) | Foodstuff comprising an extract of a plant of the genus salacia and flavonoid | |
BRPI0714456A2 (pt) | composiÇço e mÉtodo para tratar, prevenir, ou melhorar a diabete ou complicaÇÕes diabÉticas | |
US20070264368A1 (en) | Carbohydrase inhibitors derived from fagaceous plants and use thereof | |
JP5442243B2 (ja) | 腎障害抑制剤 | |
CN111034999A (zh) | 一种具有抗糖减重功能的组合物 | |
CN106723015A (zh) | 一种具有抗疲劳和抗氧化功能的保健食品及其制备工艺 | |
CN114223904B (zh) | 一种美白抗糖保健品的配方 | |
US20150132338A1 (en) | Composition for food and fat absorption inhibitor | |
WO2005074961A1 (ja) | 体脂肪調整剤 | |
JP2017165672A (ja) | 多糖消化阻害剤 | |
CN1913910B (zh) | 包括北枳椇提取物,三丫乌药提取物,或其本草混合物提取物的组合物 | |
JP4516958B2 (ja) | 抗糖尿病用組成物 | |
JP2019034896A (ja) | 経口組成物 | |
US8241677B2 (en) | Foodstuff of tablets or capsules | |
KR101358197B1 (ko) | 특정 화합물을 유효성분으로 포함하는 렙틴 분비 촉진용 조성물 | |
WO2019083264A1 (ko) | 숙성새싹삼 추출물의 발효물을 유효성분으로 함유하는 간질환의 예방, 개선 또는 치료용 조성물 | |
JP2010254594A (ja) | 腸内バクテロイデス増殖促進剤 | |
KR20180053361A (ko) | 혈당치 상승 억제제 및 이를 포함하는 경구 조성물 | |
KR101808808B1 (ko) | 벌나무 및 후박나무 추출물을 함유하는 당뇨병 또는 당뇨합병증 예방 및 치료용 조성물 | |
KR101250198B1 (ko) | 특정 화합물을 유효성분으로 포함하는 식욕억제 식품성분 조성물 | |
KR100656086B1 (ko) | 인진쑥 추출물과 그를 함유한 식후과혈당 억제용 조성물 | |
JP7090267B2 (ja) | 血糖値上昇抑制剤 | |
KR20240003002A (ko) | 마치현을 유효성분으로 포함하는 근육감소 방지용 조성물 | |
WO2013133677A1 (ko) | 홍삼 추출물의 감식초 반응 혼합물을 함유한 혈관 질환의 예방 또는 치료용 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |